Sangamo Therapeutics
Price & Volume
Stats
See more52W Range | $0.21-$0.84 |
Market Cap | $108.4M |
Shares Short | 33M |
Financials
See moreRevenue (12 Mos) | $39.5M |
Revenue Growth (YoY) | 88.4% |
Gross Profit (12 Mos) | -$73.1M |
Diluted EPS | -$0.44 |
News
See moreYahoo Finance • 11 days ago
Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results
Yahoo Finance • 11 days ago
After-Hours Earnings Report for March 30, 2026 : PRGS, PHR, DMAC, AIRJ, SPCE, HQI, SGMO, RNXT, INLX, FTHM
Yahoo Finance • 11 days ago
Here are the major earnings after the close Monday
Yahoo Finance • 12 days ago
Earnings week ahead: NKE, TLRY, SPCE, BYND, NNDM, CAG, and more
About
CEO | Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D. |
Address | 501 Canal Blvd, Richmond, CA, United States, 94804 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 183 |
